Global Helicobacter Pylori Testing Market to amass $ 560 Mn by 2025

December 16, 2019


According to the research report titled ‘Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, Romania, Russia, China, India, Australia, South Korea, Brazil, Mexico, Chile, Argentina, South Africa, Saudi Arabia, Nigeria, Turkey), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global helicobacter pylori testing market is estimated to cross USD 560 million by the year 2025.
 

Growing occurrences of gastric ulcers across the globe is a major factor driving the helicobacter pylori testing market. Development of innovative products, FDA approvals, and favorable federal initiatives promoting the importance of early and proper diagnosis are further aiding the helicobacter pylori testing market outlook. Increasing prevalence of infectious diseases coupled with rising elderly population is augmenting the demand for helicobacter pylori non-invasive treatments across the globe.
 

In terms of type of treatment, non-invasive helicobacter pylori testing segment is registering growth as compared to invasive treatment. Rising adoption of non-invasive helicobacter pylori treatments is fueling the segmental growth. Non-invasive treatments are available at low-cost and offer rapid diagnosis as compared to its counterpart.
 

As per type of method, the POC (Point-of-care) test is expected to grow substantially during the forecast period. POC tests provide accurate results in minimum time span and are available at low costs. Rising number of initiatives by various worldwide governments to reduce disease burden and control target disease are augmenting the demand for POC testing systems.
 

Request sample copy of this Reporthttps://www.marketstudyreport.com/request-a-sample/2337488/
 

Considering the geographical landscape, the report cites that Middle East & Africa helicobacter pylori testing market will grow with a CAGR of 7.9% during the period of 2019-2025. This is attributed to advancement in healthcare facilities, rising development of infrastructure and escalating consumer disposable incomes across the region. Moreover, growing occurrences of peptic ulcers and cancers and favorable federal reforms which encourage enhancement of helicobacter pylori testing solutions is contributing towards the market expansion.
 

The prominent companies operating in the helicobacter pylori testing market are Cardinal Health, Bio-Rad Laboratories, Abbott, Gulf Coast Scientific, Exalenz Bioscience Ltd., Quidel Corp., Thermo Fisher and Meridian Bioscience.


Frequently Asked Questions (FAQ) :

Growing occurrences of gastric ulcers across the globe is a major factor driving the helicobacter pylori testing market. Development of innovative products, FDA approvals, and favorable federal initiatives promoting the importance of early and proper diagnosis are further aiding the helicobacter pylori testing market outlook. Increasing prevalence of infectious diseases coupled with rising elderly population is augmenting the demand for helicobacter pylori non-invasive treatments across the globe.
Non-invasive helicobacter pylori testing market is registering growth as compared to invasive treatment. Rising adoption of non-invasive helicobacter pylori treatments is fueling the segmental growth. Non-invasive treatments are available at low-cost and offer rapid diagnosis as compared to its counterpart.
Middle East & Africa helicobacter pylori testing market will grow with a CAGR of 7.9% during the period of 2019-2025. This is attributed to advancement in healthcare facilities, rising development of infrastructure and escalating consumer disposable income across the region. Moreover, growing occurrences of peptic ulcers and cancers and favorable federal reforms which encourage enhancement of helicobacter pylori testing solutions are contributing towards the market expansion.
The prominent companies operating in the helicobacter pylori testing market are Cardinal Health, Bio-Rad Laboratories, Abbott, Gulf Coast Scientific, Exalenz Bioscience Ltd., Quidel Corp., Thermo Fisher and Meridian Bioscience.